De Vivo DC, Trifiletti RR, Jacobson RI, Ronen GM, Behmand RA, Harik SI (1991) Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med 325:703–709. https://doi.org/10.1056/NEJM199109053251006

Article  PubMed  Google Scholar 

Klepper J, Akman C, Armeno M, Auvin S, Cervenka M, Cross HJ et al (2020) Glut1 Deficiency Syndrome (Glut1DS): State of the art in 2020 and recommendations of the international Glut1DS study group. Epilepsia Open 5:354–365. https://doi.org/10.1002/epi4.12414

Article  PubMed  PubMed Central  Google Scholar 

Wang D, Pascual JM, De Vivo D (2018) Glucose Transporter Type 1 Deficiency Syndrome. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A (eds) GeneReviews® [Internet]. Seattle (WA), University of Washington, Seattle, pp 1993–2024

Cano A, Ticus I, Chabrol B (2008) Glucose transporter type 1 (GLUT-1) deficiency. Rev Neurol (Paris) 164:896–901. https://doi.org/10.1016/j.neurol.2008.02.033

Article  CAS  PubMed  Google Scholar 

Brockmann K (2009) The expanding phenotype of GLUT1-deficiency syndrome. Brain Dev 31:545–552. https://doi.org/10.1016/j.braindev.2009.02.008

Article  PubMed  Google Scholar 

Varesio C, Pasca L, Parravicini S, Zanaboni MP, Ballante E, Masnada S et al (2019) Quality of life in chronic ketogenic diet treatment: the GLUT1DS population perspective. Nutrients 11:1650. https://doi.org/10.3390/nu11071650

Article  PubMed  PubMed Central  Google Scholar 

Bekker YAC, Lambrechts DA, Verhoeven JS, van Boxtel J, Troost C, Kamsteeg E-J et al (2019) Failure of ketogenic diet therapy in GLUT1 deficiency syndrome. Eur J Paediatr Neurol 23:404–409. https://doi.org/10.1016/j.ejpn.2019.02.012

Article  PubMed  Google Scholar 

Comella CL, Leurgans S, Wuu J, Stebbins GT, Chmura T, The Dystonia Study Group (2003) Rating scales for dystonia: a multicenter assessment. Mov Disord 18:303–12. https://doi.org/10.1002/mds.10377

Article  PubMed  Google Scholar 

Sun S (1993) Reduced representation model of protein structure prediction: statistical potential and genetic algorithms. Protein Sci 2:762–785. https://doi.org/10.1002/pro.5560020508

Article  CAS  PubMed  PubMed Central  Google Scholar 

Melo F, Sánchez R, Sali A (2002) Statistical potentials for fold assessment. Protein Sci 11:430–448. https://doi.org/10.1002/pro.110430

Article  CAS  PubMed  PubMed Central  Google Scholar 

Deng D, Xu C, Sun P, Wu J, Yan C, Hu M et al (2014) Crystal structure of the human glucose transporter GLUT1. Nature 510:121–125. https://doi.org/10.1038/nature13306

Article  CAS  PubMed  Google Scholar 

Klepper J, Leiendecker B (2007) GLUT1 deficiency syndrome—2007 update. Dev Med Child Neurol 49:707–716. https://doi.org/10.1111/j.1469-8749.2007.00707.x

Article  PubMed  Google Scholar 

Mueckler M, Caruso C, Baldwin SA, Panico M, Blench I, Morris HR et al (1985) Sequence and structure of a human glucose transporter. Science 229:941–945. https://doi.org/10.1126/science.3839598

Article  CAS  PubMed  Google Scholar 

Larsen J, Johannesen KM, Ek J, Tang S, Marini C, Blichfeldt S et al (2015) The role of SLC2A1 mutations in myoclonic astatic epilepsy and absence epilepsy, and the estimated frequency of GLUT1 deficiency syndrome. Epilepsia 56:e203-208. https://doi.org/10.1111/epi.13222

Article  CAS  PubMed  Google Scholar 

Felmlee MA, Jones RS, Rodriguez-Cruz V, Follman KE, Morris ME (2020) Monocarboxylate transporters (SLC16): function, regulation, and role in health and disease. Pharmacol Rev 72:466–485. https://doi.org/10.1124/pr.119.018762

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cappuccio G, Pinelli M, Alagia M, Donti T, Day-Salvatore D-L, Veggiotti P et al (2017) Biochemical phenotyping unravels novel metabolic abnormalities and potential biomarkers associated with treatment of GLUT1 deficiency with ketogenic diet. PLoS One 12:e0184022. https://doi.org/10.1371/journal.pone.0184022

Article  CAS  PubMed  PubMed Central  Google Scholar 

Leen WG, Klepper J, Verbeek MM, Leferink M, Hofste T, van Engelen BG et al (2010) Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder. Brain 133:655–670. https://doi.org/10.1093/brain/awp336

Article  PubMed  Google Scholar 

Leary LD, Wang D, Nordli DR, Engelstad K, De Vivo DC (2003) Seizure characterization and electroencephalographic features in Glut-1 deficiency syndrome. Epilepsia 44:701–707. https://doi.org/10.1046/j.1528-1157.2003.05302.x

Article  PubMed  Google Scholar 

Klepper J, Scheffer H, Leiendecker B, Gertsen E, Binder S, Leferink M et al (2005) Seizure control and acceptance of the ketogenic diet in GLUT1 deficiency syndrome: a 2- to 5-year follow-up of 15 children enrolled prospectively. Neuropediatrics 36:302–308. https://doi.org/10.1055/s-2005-872843

Article  CAS  PubMed  Google Scholar 

Klepper J (2012) GLUT1 deficiency syndrome in clinical practice. Epilepsy Res 100:272–277. https://doi.org/10.1016/j.eplepsyres.2011.02.007

Article  CAS  Google Scholar 

Alter AS, Engelstad K, Hinton VJ, Montes J, Pearson TS, Akman CI et al (2015) Long-term clinical course of Glut1 deficiency syndrome. J Child Neurol 30:160–169. https://doi.org/10.1177/0883073814531822

Article  PubMed  Google Scholar 

Hao J, Kelly DI, Su J, Pascual JM (2017) Clinical aspects of glucose transporter type 1 deficiency: information from a global registry. JAMA Neurol 74:727–732. https://doi.org/10.1001/jamaneurol.2017.0298

Article  PubMed  PubMed Central  Google Scholar 

Logel SN, Connor EL, Hsu DA, Fenske RJ, Paloian NJ, De Vivo DC (2021) Exploring diazoxide and continuous glucose monitoring as treatment for Glut1 deficiency syndrome. Ann Clin Transl Neurol 8:2205–2209. https://doi.org/10.1002/acn3.51462

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tchapyjnikov D, Mikati MA (2018) Acetazolamide-responsive episodic ataxia without baseline deficits or seizures secondary to GLUT1 deficiency: a case report and review of the literature. Neurologist 23:17–18. https://doi.org/10.1097/NRL.0000000000000168

Article  PubMed  Google Scholar 

Ordoñez R, Zhang W, Ellis G, Zhu Y, Ashe HJ, Ribeiro-Dos-Santos AM et al (2023) Genomic context sensitizes regulatory elements to genetic disruption. bioRxiv [Preprint]. https://doi.org/10.1101/2023.07.02.547201

Vulturar R, Chiș A, Pintilie S, Farcaș IM, Botezatu A, Login CC et al (2022) One molecule for mental nourishment and more: glucose transporter type 1—biology and deficiency syndrome. Biomedicines 10:1249. https://doi.org/10.3390/biomedicines10061249

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chang P, Augustin K, Boddum K, Williams S, Sun M, Terschak JA et al (2016) Seizure control by decanoic acid through direct AMPA receptor inhibition. Brain 139:431–443. https://doi.org/10.1093/brain/awv325

Article  PubMed  Google Scholar 

Sakai H, Fujii Y, Kuwayama N, Kawaji K, Gotoh Y, Kishi Y (2019) Plag1 regulates neuronal gene expression and neuronal differentiation of neocortical neural progenitor cells. Genes Cells 24:650–666. https://doi.org/10.1111/gtc.12718

Article  CAS  PubMed  Google Scholar 

Li J, O’Leary EI, Tanner GR (2017) The ketogenic diet metabolite beta-hydroxybutyrate (β-HB) reduces incidence of seizure-like activity (SLA) in a Katp- and GABAb-dependent manner in a whole-animal Drosophila melanogaster model. Epilepsy Res 133:6–9. https://doi.org/10.1016/j.eplepsyres.2017.04.003

Article  CAS  PubMed  Google Scholar 

Lopes EF, Roberts BM, Siddorn RE, Clements MA, Cragg SJ (2019) Inhibition of nigrostriatal dopamine release by striatal GABAA and GABAB receptors. J Neurosci 39:1058–1065. https://doi.org/10.1523/JNEUROSCI.2028-18.2018

Article  CAS  PubMed  PubMed Central  Google Scholar 

Avshalumov MV, Rice ME (2003) Activation of ATP-sensitive K+ (K(ATP)) channels by H2O2 underlies glutamate-dependent inhibition of striatal dopamine release. Proc Natl Acad Sci U S A 100:11729–11734. https://doi.org/10.1073/pnas.1834314100

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ferré S, Torvinen M, Antoniou K, Irenius E, Civelli O, Arenas E et al (1998) Adenosine A1 receptor-mediated modulation of dopamine D1 receptors in stably cotransfected fibroblast cells. J Biol Chem 273:4718–4724. https://doi.org/10.1074/jbc.273.8.4718

Article  PubMed  Google Scholar 

Cortés A, Casadó-Anguera V, Moreno E, Casadó V (2019) The heterotetrameric structure of the adenosine A1-dopamine D1 receptor complex: Pharmacological implication for restless legs syndrome. Adv Pharmacol 84:37–78. https://doi.org/10.1016/bs.apha.2019.01.001

Article  CAS  PubMed  Google Scholar 

Striano P, Auvin S, Collins A, Horvath R, Scheffer IE, Tzadok M et al (2022) A randomized, double-blind trial of triheptanoin for drug-resistant epilepsy in glucose transporter 1 deficiency syndrome. Epilepsia 63:1748–1760. https://doi.org/10.1111/epi.17263

Article  CAS  PubMed  PubMed Central  Google Scholar 

Varesio C, De Giorgis V, Veggiotti P, Nardocci N, Granata T, Ragona F et al (2023) GLUT1-DS Italian registry: past, present, and future: a useful tool for rare disorders. Orphanet J Rare Dis 18:63.